Search Within

Bradley Beattie

  1. "Howard Scher"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (2)
Groups
  1. Department of Medicine (8)
  2. GSK Faculty (8)
  3. Genitourinary Oncology Service (8)
  4. Medical Physics (8)
  5. Molecular Imaging and Therapy Service (8)
  6. Molecular Pharmacology and Chemistry Program Faculty (8)

More Groups

People
  1. Howard Scher (8)
  2. Steven Larson (8)
  3. John Humm (7)
  4. Michael Morris (7)
  5. Pat Zanzonico (5)
  6. Ronald Finn (5)

More People

Years
  1. 2018 (3)
  2. 2010 (1)
  3. 2004 (2)
  4. 2003 (1)
  5. 2002 (1)
Publications
  1. Journal of Nuclear Medicine (6)
  2. JAMA Oncology (1)
  3. Nature Communications (1)
Publishers
  1. Society of Nuclear Medicine (6)
  2. American Medical Association (1)
  3. Nature Publishing Group (1)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Reproducibility and repeatability of semiquantitative (18)F-fluorodihydrotestosterone uptake metrics in castration-resistant prostate cancer metastases: A prospective multicenter study
    Journal Article

    Vargas, H. A.; Kramer, G. M.; Scott, A. M.; Weickhardt, A.; Meier, A. A.; Parada, N.; Beattie, B. J.; Humm, J. L.; Staton, K. D.; Zanzonico, P. B.; more...
    Journal of Nuclear Medicine (2018)

    Fulltext@MSK | Save
  • Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
    Journal Article

    McDevitt, M. R.; Thorek, D. L. J.; Hashimoto, T.; Gondo, T.; Veach, D. R.; Sharma, S. K.; Kalidindi, T. M.; Abou, D. S.; Watson, P. A.; Beattie, B. J.; more...
    Nature Communications (2018)

    Fulltext@MSK | Save
  • Positron emission tomography/computed tomography-based assessments of androgen receptor expression and glycolytic activity as a prognostic biomarker for metastatic castration-resistant prostate cancer
    Journal Article

    Fox, J. J.; Gavane, S. C.; Blanc-Autran, E.; Nehmeh, S.; Gonen, M.; Beattie, B.; Vargas, H. A.; Schoder, H.; Humm, J. L.; Fine, S. W.; more...
    JAMA Oncology (2018)

    Fulltext@MSK | Save
  • Pharmacokinetic assessment of the uptake of 16β-18F-fluoro- 5α-dihydrotestosterone (FDHT) in prostate tumors as measured by PET
    Journal Article

    Beattie, B. J.; Smith-Jones, P. M.; Jhanwar, Y. S.; Schoder, H.; Ross Schmidtlein, C.; Morris, M. J.; Zanzonico, P.; Squire, O.; Meirelles, G. S. P.; Finn, R.; more...
    Journal of Nuclear Medicine (2010)

    Fulltext@MSK | Save
  • Tumor localization of 16β-(18)F-fluoro-5α- dihydrotestosterone versus (18)F-FDG in patients with progressive, metastatic prostate cancer
    Journal Article

    Larson, S. M.; Morris, M.; Guenther, I.; Beattie, B.; Humm, J. L.; Akhurst, T.; Finn, R. D.; Erdi, Y.; Pentlow, K.; Dyke, J.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save
  • PET-based radiation dosimetry in man of 18F- fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer
    Journal Article

    Zanzonico, P. B.; Finn, R.; Pentlow, K. S.; Erdi, Y.; Beattie, B.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; McCarthy, T.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save
  • Tumor localization of [18F]-Fluoro-Dihydro-testosterone (FDHT) versus [18F]-2-Fluoro-D-glucose (FDG) in patients with progressive, metastatic prostate cancer
    Meeting Abstract

    Larson, S. M.; Gunther, I.; Morris, M.; Beattie, B.; Akhurst, T. A.; Finn, R.; Pentlow, K.; Zanzonico, P.; Erdi, Y.; Humm, J.; more...
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • PET-based radiation dosimetry in man of F-18-fluorodihydrotestosterone (FDHT), a new radiotracer for imaging prostate cancer
    Meeting Abstract

    Zanzonico, P.; Finn, R.; Pentlow, K. S.; Erdi, Y.; Beattie, B.; Humm, J.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; more...
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save